The optimal target for acute glycemic control in critically ill patients: A network meta-analysis.
The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.
Abstract
Purpose The optimal target blood glucose concentration for acute glycemic control remains unclear because few studies have directly compared 144-180 with 110-144 or >180 mg/dL. Accordingly, we performed a network meta-analysis to compare four different target blood glucose levels ( 180 mg/dL) in terms of the benefit and risk of insulin therapy. Methods We included all of the studies from three systematic reviews and searched the PubMed and Cochrane databases for other studies investigating glucose targets among critically ill patients. The primary outcome was hospital mortality, and the secondary outcomes were sepsis or bloodstream infection and the risk of hypoglycemia. Network meta-analysis to identify an optimal target glucose concentration. Results The network meta-analysis included 18,098 patients from 35 studies. There were no significant differences in the risk of mortality and infection among the four blood glucose ranges overall or in subgroup analysis. Conversely, target concentrations of 180 mg/dL. However, there were no significant differences between the target concentrations of 144-180 and >180 mg/dL. Conclusions This network meta-analysis found no significant difference in the risk of mortality and infection among four target blood glucose ranges in critically ill patients, but indicated that target blood glucose levels of 180 mg/dL. Further studies are required to refute or confirm our findings.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“No significant difference in the risk of hospital mortality was observed between the four blood glucose ranges.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [519]
In the citing paper
“Target concentrations of < 110 and 110–144 mg/dL were associated with a four to nine-fold increase in the risk of hypoglycemia compared with 144–180 and > 180 mg/dL.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [519]
In the citing paper
“No significant difference in the risk of hypoglycemia comparing a target of 144–180 and > 180 mg/dL was demonstrated (OR 1.72; 95% CI 0.79–3.7).”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [519]
Citations
Cites
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J. P. T., Green, S. R., & Higgins, J. P. T. (2008) · Cited by 7,226
Intravenous Fluids and Acute Kidney Injury
Ding, X., Cheng, Z., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452702 · Cited by 6,827
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119 · cited 2×
“In 2009, the landmark Normoglycemia in Intensive Care Evaluation and Surviving Using Glucose Algorithm Regulation (NICE-SUGAR) trial reported that IIT (target blood glycemic range, 80–108 mg/dL) increased mortality among critical ill patients compared with an intermediate level of glycemic control (144–180 mg/dL) [9].”
BackgroundFamily history of subarachnoid haemorrhage: supplemental value of scrutinizing all relatives.
Greebe, P., Bromberg, J. E., Rinkel, G. J., Algra, A., & van Gijn, J. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.3.273 · Cited by 4,139
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 1×
“Subsequently, several studies reported that tight glycemic control reduced mortality and morbidity at certain centers and in selected populations [3, 4].”
BackgroundIntensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921
Research works printed but not linked: 1
- Mackenzie IM, Ercole A, Ingle S, Palmer CR (2008) Glycaemic control and outcome in general intensive care: the East Anglian GLYCOGENIC study. Br J Intensive Care 18:121–126
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
ESPEN guideline on clinical nutrition in the intensive care unit.
Singer, P., Blaser, A. R., Berger, M. M., Alhazzani, W., Calder, P. C., Casaer, M. P., Hiesmayr, M., Mayer, K., Montejo, J. C., Pichard, C., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.08.037 · Cited by 2,904
ESPEN practical and partially revised guideline: Clinical nutrition in the intensive care unit
Singer, P., Blaser, A. R., Berger, M. M., Calder, P. C., Casaer, M., Hiesmayr, M., Mayer, K., Montejo-Gonzalez, J. C., Pichard, C., Preiser, J.-C., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.07.011 · Cited by 793
“The glycemic target associated with the best adjusted outcome ranges from 80 to 150 to 140 e 180 mg/dL (7.8 e 10 mmol/L), which is different from the blood glucose levels actually achieved [139].”
BackgroundInfluentialPeden, C. J., Aggarwal, G., Aitken, R. J., Anderson, I. D., Bang Foss, N., Cooper, Z., Dhesi, J. K., French, W. B., Grant, M. C., Hammarqvist, F., et al. (2021) · World Journal of Surgery · doi:10.1007/s00268-021-05994-9 · Cited by 171
Nanchal, R., Subramanian, R., Karvellas, C. J., Hollenberg, S. M., Peppard, W. J., Singbartl, K., Truwit, J., Al-Khafaji, A. H., Killian, A. J., Alquraini, M., et al. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004192 · Cited by 153
Hyperglycemia in acute ischemic stroke: physiopathological and therapeutic complexity
Ferrari, F., Moretti, A., & Villa, R. F. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.317959 · Cited by 126
“1 mM is associated with 4-fold to 9-fold increased risk of hypoglycemia (Yatabe et al., 2017), which after i.”
BackgroundInfluentialSeminario‐Vidal, L., Kroshinsky, D., Malachowski, S. J., Sun, J. X., Markova, A., Beachkofsky, T. M., Kaffenberger, B. H., Ergen, E. N., Mauskar, M., Bridges, A. G., et al. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.02.066 · Cited by 124
Klonoff, D. C., Messler, J., Umpierrez, G. E., Peng, L., Booth, R., Crowe, J., Garrett, V., McFarland, R., & Pasquel, F. J. (2020) · Diabetes Care · doi:10.2337/dc20-1857 · Cited by 122
European Stroke Organisation (ESO) guidelines on glycaemia management in acute stroke
Fuentes, B., Ntaios, G., Putaala, J., Thomas, B. M., Turc, G., & Díez‐Tejedor, E. (2017) · European Stroke Journal · doi:10.1177/2396987317742065 · Cited by 85
“9mmol/L (144–180mg/ dL).(63) Thus, future clinical trials should be aimed to achieve a ‘physiologic’ normalisation with well-controlled IV insulin infusion rather than intensive reduction of glucose levels and avoiding roller-coaster effects produced by intermittent SC insulin administration that are not currently rec…”
BackgroundAdvances in Medical Nutrition Therapy: Parenteral Nutrition
Itzhaki, M. H., & Singer, P. (2020) · Nutrients · doi:10.3390/nu12030717 · Cited by 74
“According to current data, no specific glucose concentration range below the value of 180 mg/dL has further mortality benefits [54].”
BackgroundIs intensive glucose control bad for critically ill patients? A systematic review and meta-analysis
Yao, R.-Q., Ren, C., Wu, G., Zhu, Y., Xia, Z., & Yao, Y.-M. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.43447 · Cited by 70
“Strikingly, our meta-analysis drew discrepant conclusions when compared with the conclusions of previously published meta-analyses [25-29].”
BackgroundMethodResultInfluentialSurviving Sepsis After Burn Campaign
Greenhalgh, D. G., Hill, D. M., Burmeister, D. M., Gus, E. I., Cleland, H. J., Padiglione, A. A., Holden, D., Huss, F. R. M., Chew, M. S., Kubasiak, J., et al. (2023) · Burns · doi:10.1016/j.burns.2023.05.003 · Cited by 65
Poole, A. P., Finnis, M., Anstey, J. R., Bellomo, R., Bihari, S., Biradar, V., Doherty, S., Eastwood, G. M., Finfer, S. R., French, C., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202202-0329oc · Cited by 63
Intensive care management of acute-on-chronic liver failure
Bernal, W. E., Karvellas, C. J., Saliba, F., Saner, F. H., & Meersseman, P. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.10.024 · Cited by 58
Yao, M., Hao, Y., Wang, T., Xie, M., Li, H., Feng, J., Feng, L., & Ma, D. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1149671 · Cited by 55
Glycemic control in the critically ill: Less is more
Alhatemi, G., Aldiwani, H., Alhatemi, R., Hussein, M., Mahdai, S., & Seyoum, B. (2022) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.89a.20171 · Cited by 53
“In attempts to fi nd an optimal blood glucose target, Yamada et al 57 and Yatabe et al 58 performed network meta-analyses of published RCTs comparing insulin regimens in critically ill adults with hyperglycemia.”
Raurell‐Torredà, M., Arias-Rivera, S., Martí, J.-D., Mera, M. J. F., Zaragoza‐García, I., Gallart, E., Sanz, T. R. V., José-Arribas, A. S., Blázquez-Martínez, E., Delgado, M. E. R., et al. (2018) · Enfermería Intensiva · doi:10.1016/j.enfi.2018.04.004 · Cited by 49
Enhanced perioperative care in emergency general surgery: the WSES position paper
Ceresoli, M., Braga, M., Zanini, N., Abu‐Zidan, F. M., Parini, D., Länger, T., Sartelli, M., Damaskos, D., Biffl, W. L., Amico, F., et al. (2023) · World Journal of Emergency Surgery · doi:10.1186/s13017-023-00519-2 · Cited by 48
“centrations (< 110, 110–144, 144–180, and > 180 mg/dL) in terms of the benefit and risk of insulin therapy found no significant difference in the risk of mortality and infection among four target blood glucose ranges in critically ill patients, but indicated that target blood glucose levels of below 144 mg/dL were ass…”
BackgroundS3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge – Update 2025
Brunkhorst, F. M., Adamzik, M., Axer, H., Bauer, M. W., Bode, C., Bone, H.-G., Brenner, T., Bucher, M., David, S., Dietrich, M., et al. (2025) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-025-01317-1 · Cited by 47
Hyperglycemia in Medically Critically Ill Patients: Risk Factors and Clinical Outcomes
Becker, C. D., Sabang, R. L., Cordeiro, M. F. N., Hassan, I. F., Goldberg, M. D., & Scurlock, C. S. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2020.03.012 · Cited by 43
Wang, W., Chen, W., Liu, Y., Li, L., Li, S., Tan, J., & Sun, X. (2019) · Journal of Intensive Care Medicine · doi:10.1177/0885066619889322 · Cited by 39
“However, the linearity hypothesis was not supported by previous trials (eg, the action to control cardiovascular risks in diabetes study [ACCORD] and the action in diabetes and vascular disease [ADVANCE](45,46)), and earlier meta-analyses showed that tight glycemic control (<110 mg/ dL) had no benefit on mortality in…”
ResultYatabe, T., Inoue, S., Sakamoto, S., Sumi, Y., Nishida, O., Hayashida, K., Hara, Y., Fukuda, T., Matsushima, A., Matsuda, A., et al. (2018) · Thrombosis Research · doi:10.1016/j.thromres.2018.10.007 · Cited by 34
Self-citationZhang, L., Wang, Z., Xu, F., Han, D., Li, S., Yin, H., & Lyu, J. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.683932 · Cited by 30
“Althoughmany scholars have conducted studies on the optimal range of blood glucose control in critically ill patients, no unified standard is available as of yet (37).”
BackgroundZinter, M. S., Markovic, D., Asaro, L. A., Nadkarni, V., McQuillen, P. S., Sinha, P., Matthay, M. A., Jeschke, M. G., Agus, M. S. D., & Sapru, A. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202210-1988le · Cited by 29
“These results are consistent with previous studies showing the detrimental effect of PAI-1 in pleural injury (2, 3).”
Glycemic targets in critically ill adults: A mini-review
See, K. C. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i10.1719 · Cited by 28
Zhao, K., Zhang, Y., Li, J., Cui, Q., Zhao, R., Chen, W., Liu, J., Zhao, B., Wan, Y., Ma, X., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.012376 · Cited by 26
Metabolism of Microbiota in Critical Illness (Review and Postulates)
Nv, B. (2019) · General Reanimatology · doi:10.15360/1813-9779-2019-6-62-79 · Cited by 22
Plummer, M. P., Notkina, N., Timofeev, I. S., Hutchinson, P. J., Finnis, M., & Gupta, A. K. (2018) · Critical Care · doi:10.1186/s13054-017-1933-5 · Cited by 21
“Current management of hyperglycaemia in TBI involves the use of intravenous infusions of shortacting insulin, titrated to maintain systemic blood glucose within target ranges that have largely been derived from randomised controlled trials in general medical, surgical or heterogeneous critically ill populations [5].”
BackgroundThe optimal glycemic target in critically ill patients: an updated network meta-analysis
Tanaka, A., Yatabe, T., Suhara, T., & Egi, M. (2024) · Journal of Intensive Care · doi:10.1186/s40560-024-00728-0 · Cited by 20
“The patients were divided into four groups based on the upper limit of the target blood glucose level: < 110, 110–144, 144–180, or > 180 mg/dL [3, 4].”
BackgroundSelf-citationLin, S., He, W., & Zeng, M. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s287510 · Cited by 16
Glycemic control in acute illness
Egi, M., Furushima, N., Makino, S., & Mizobuchi, S. (2017) · Korean Journal of Anesthesiology · doi:10.4097/kjae.2017.70.6.591 · Cited by 16
“patients from 35 RCTs) to determine the optimal target in acute illness [25].”
BackgroundSelf-citationChinese Guidelines for Medical Nutrition Therapy for Patients with Diabetes (2022 Edition).
(2024) · PubMed Central · doi:10.6133/apjcn.202406_33(2).0001 · Cited by 15
Incidence and Impact of Dysglycemia in Patients with Sepsis Under Moderate Glycemic Control
Fujishima, S., Gando, S., Saitoh, D., Kushimoto, S., Ogura, H., Abe, T., Shiraishi, A., Mayumi, T., Sasaki, J., Kotani, J., et al. (2021) · Shock · doi:10.1097/shk.0000000000001794 · Cited by 15
“to 180 mg/dL, referring to the results of an original network meta-analysis (10, 11).”
BackgroundDesgrouas, M., Demiselle, J., Stiel, L., Brunot, V., Marnai, R., Sarfati, S., Fiancette, M., Lambiotte, F., Thille, A. W., Leloup, M., et al. (2023) · Annals of Intensive Care · doi:10.1186/s13613-023-01142-9 · Cited by 14
“One may assume that worldwide clinical practices evolved the same way, despite a meta-analyse showing no effect of different targeted blood glucose ranges on mortality [26].”
BackgroundTamura, T., Yatabe, T., Namikawa, T., Hanazaki, K., & Yokoyama, M. (2018) · Journal of Artificial Organs · doi:10.1007/s10047-018-1082-x · Cited by 14
Self-citationZhou, D., Li, Z., Shi, G.-Z., & Zhou, J. (2020) · Medicine · doi:10.1097/md.0000000000021728 · Cited by 14
Teotia, K., Jia, Y., Woite, N. L., Celi, L. A., de Matos, J. C. R. G., & Struja, T. (2024) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2024.104643 · Cited by 13
Intensive glucose control for critically ill patients: an updated meta-analysis
Fu, Y., Sun, Y., Zhang, J., & Cheng, Y. (2018) · Endocrine Connections · doi:10.1530/ec-18-0393 · Cited by 13
The Long and Winding Road to Personalized Glycemic Control in the Intensive Care Unit
Tickoo, M. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1697603 · Cited by 12
Regulation of pancreatic Exocrine Function by Islet Hormones
Sans, M. D., Bruce, J., & Williams1, J. A. (2020) · doi:10.3998/panc.2020.01 · Cited by 12
Hung, K.-Y., Tsai, Y., Lin, C.-Y., Chang, Y.-C., Wang, Y.-H., Lin, M., & Fang, W. (2021) · Diagnostics · doi:10.3390/diagnostics11101798 · Cited by 10
“therapy has not been suggested for glycemic control in critically ill patients with sepsis due to the risk of hypoglycemia [26,27] and is not recommended for widespread adoption in medical ICUs [28,29].”
BackgroundRaurell‐Torredà, M., Arias-Rivera, S., Martí, J.-D., Mera, M. J. F., Zaragoza‐García, I., Gallart, E., Sanz, T. R. V., José-Arribas, A. S., Blázquez-Martínez, E., Delgado, M. E. R., et al. (2019) · Enfermería Intensiva (English ed ) · doi:10.1016/j.enfie.2019.04.002 · Cited by 10
Luethi, N., Cioccari, L., Eastwood, G. M., Biesenbach, P., Morgan, R., Sprogis, S. K., Young, H., Peck, L., Chong, C. K., Moore, S., et al. (2019) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.13354 · Cited by 10
Deep Learning–based Classification of Fibrotic Lung Disease: Can Computer Vision See the Future?
Choi, B., & Ash, S. Y. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202206-1036ed · Cited by 10
Egi, M. (2018) · Journal of Intensive Care · doi:10.1186/s40560-018-0337-1 · Cited by 9
Self-citationWhat have we learned from network meta-analyses applied to critical care?
Pravia, O. V. B., Montes-Andujar, L., Menéndez, J., & Cardinal‐Fernández, P. (2019) · Minerva Anestesiologica · doi:10.23736/s0375-9393.19.13267-1 · Cited by 9
Gershoni, T., Ritholz, M. D., Horwitz, D. L., Manejwala, O., Donaldson-Pitter, T., & Fundoiano-Hershcovitz, . (2022) · Applied Sciences · doi:10.3390/app13010431 · Cited by 8
The state of variability: A vision for descriptors of glycaemia
Zhou, T., Knopp, J. L., & Chase, J. G. (2019) · Annual Reviews in Control · doi:10.1016/j.arcontrol.2019.06.004 · Cited by 8
The optimal blood glucose target in critically ill patients: more questions than answers
Gunst, J., & Doig, G. S. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4610-2 · Cited by 8
“Both network metaanalyses included RCTs investigating different blood glucose targets in adult critically ill patients and categorized study groups into four treatment groups based on the target blood glucose level: a tight blood glucose control group (80–110 mg/dl), a moderate (110–140 or 110–144 mg/dl in [9], respec…”
BackgroundMethodBlood glucose control in the ICU: how tight?
Gunst, J., & den Berghe, G. V. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.01.45 · Cited by 8
“categorized the study arms from the included RCTs into four different treatment categories, going from tight blood glucose control (<110 mg/dL), over intermediate (110–144 and 144–180 mg/dL) to liberal blood glucose control (>180 mg/dL) (14).”
BackgroundMethodZheng, R., Ni, W., Shi, Y., Qian, S., & Lin, L. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-025-12467-0 · Cited by 7
“While early studies suggested that intensive glycemic control could improve survival [4, 5], the landmark NICE-SUGAR trial refuted this notion, demonstrating that such strategies increase the risk of severe hypoglycemia and mortality [6].”
Effect of liberal glucose control on critically ill patients: a systematic review and meta-analysis
Ma, J., Wang, X., Zhang, Y., & Ge, C. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-01864-w · Cited by 6
“Interestingly, our meta-analysis drew different conclusions compared to previous meta-analyses that have been published [14, 29–32].”
Huang, M. L., Yang, L., Zhang, C., & Gan, X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24545 · Cited by 6
“As the goal of glycaemic control for critically ill patients has changed from “ strict ” to “ loose ” in recent years [39] and more scientific and standardized IIPs are used, hypoglycaemia in patients caused by insulin infusion is declining.”
BackgroundFocus on randomised clinical trials
Perner, A., Hjortrup, P. B., & Pettilä, V. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5468-2 · Cited by 6
Zinter, M. S., Taylor, C. S., Markovic, D., Pellegrini, M. A., Wong, K. M. Y., Balliu, B., Gala, K. P., Asaro, L. A., Nadkarni, V., McQuillen, P. S., et al. (2025) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202409-1719oc · Cited by 5
Statlender, L., Robinson, E., Grossman, A., Duskin-Bitan, H., Shochat, T., Itzhaki, M. H., Fishman, G., Singer, P., Kagan, I., & Bendavid, I. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2024.11.024 · Cited by 4
Brainard, B. M., Lane, S. L., Burkitt, J. M., Boller, M., Fletcher, D. J., Crews, M. E., Fausak, E. D., & Evaluators, T. R. M. D. E. (2024) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/vec.13390 · Cited by 4
de Matos, J. C. R. G., Struja, T., Woite, N. L., Restrepo, D. S., Waschka, A. K., Celi, L. A., & Sauer, C. M. (2025) · International Journal of Cancer · doi:10.1002/ijc.70138 · Cited by 3
“41,42 for biases due to its observational design, including unmeasured confounders.”
Genay, S., Décaudin, B., Ethgen, S., Alluin, A., Babol, E., Labreuche, J., Behal, H., Vantyghem, M., Odou, P., & Lebuffe, G. (2017) · Annals of Intensive Care · doi:10.1186/s13613-017-0298-x · Cited by 3
“Tight glycaemic control of critically ill patients has no effect on mortality but causes five times as much hypoglycaemia compared to mild or very mild control [33, 34].”
BackgroundTokuhira, N., Uchiyama, A., Hoshino, T., Kubo, N., Ishigaki, S., Enokidani, Y., Sakaguchi, R., Koyama, Y., & Fujino, Y. (2022) · Artificial Organs · doi:10.1111/aor.14472 · Cited by 3
The Optimal Glycemic Control in Patients with Diabetes in the ICU: Where Is the Sweet Spot?
Hermanides, J., & Egi, M. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202206-1045ed · Cited by 3
“However, a recent network analysis concluded that there is a lack of sufficient evidence to determine the optimal target of glucose concentrations in critically ill patients with diabetes (5).”
BackgroundSelf-citationLi, M., Deng, C.-M., Su, X., Zhang, D., Ding, M., Ma, J., & Wang, D. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1003186 · Cited by 2
Enhanced recovery after surgery (ERAS) in Emergency and Trauma Surgery
Bollino, R., Yu, H., Luppi, D., & Zizzo, M. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1004115 · Cited by 2
Struja, T., de Matos, J. C. R. G., Lam, B. D., Cao, Y., Liu, X., Chan, Z., Jia, Y., Sauer, C. M., D’Couto, H. T., Dankwa‐Mullan, I., et al. (2023) · Heart & Lung · doi:10.1016/j.hrtlng.2025.03.011 · Cited by 2
Muhetaer, G., Sun, C., Ma, Q., Zhang, Y., Zhang, J., & Ning, Y. (2025) · Nursing in Critical Care · doi:10.1111/nicc.13304 · Cited by 1
Zewde, W. Z., Mamo, A., Afework, H., Desalegn, M., Hayle, E., Tsegay, Z., Netsere, M. W., Ibrahim, A. M., & Asres, Y. (2025) · International Journal of Diabetes and Endocrinology · doi:10.11648/j.ijde.20251002.11 · Cited by 1
ESPEN practical and partially revised guideline: Clinical nutrition in the intensive care unit
González, J. C. M., Singer, P., Blaser, A. R., Berger, M. M., Calder, P. C., Casaer, M. P., Hiesmayr, M., Mayer, K., Pichard, C., Preiser, J., et al. (2026) · Nutrición Hospitalaria · doi:10.20960/nh.06943 · Cited by 2
A Importância da Comissão de Controle Glicêmico Hospitalar (CCGH) no Hospital Santa Izabel
Feitosa, A. C. R. (2020) · Revista Científica Hospital Santa Izabel · doi:10.35753/rchsi.v3i2.22 · Cited by 1
Nutrition in Critical Illness During Pregnancy
Bendavid, I., & Singer, P. (2020) · Springer eBooks · doi:10.1007/978-3-030-43477-9_32 · Cited by 1
Ichaï, C., & Preiser, J. (2023) · Anesthésie & Réanimation · doi:10.1016/j.anrea.2023.06.005 · Cited by 1
Kitagawa, H., Yokota, K., Namikawa, T., Maeda, H., Kobayashi, M., & Seo, S. (2023) · Journal of Artificial Organs · doi:10.1007/s10047-023-01423-x · Cited by 1
“…report by van den Berghe et al. [7], intensive insulin therapy to control BGL to 80–110 mg/dL has been attempted; however, in the NICE-SUGAR study, intensive insulin therapy increased mortality compared to the control therapy group [8], and management below 180 mg/dL is also recommended [9, 10].”
Mainali, R. (2023) · WakeSpace Scholarship (Wake Forest University) · Cited by 1
Wen, F., Zhang, Y., Lin, C., Deng, M.-H., Zhang, J., & Zhang, J. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7537
Intensive Glucose Control for Critically Ill Patients
Conway, J., & Friedman, B. W. (2019) · Academic Emergency Medicine · doi:10.1111/acem.13777
Методичні рекомендації ESPEN щодо клінічного харчування у відділенні інтенсивної терапії
Singer, P., Blaser, A. R., Berger, M. M., Alhazzani, W. A., Calder, P. C., Casaer, M. P., Hiesmayr, M., Mayer, K., Montejo, J. C., Pichard, C., et al. (2019) · Pain anesthesia and intensive care · doi:10.25284/2519-2078.2(87).2019.171009
Significance of Blood Glucose Control in Severe Nursing Care of ICU
Huifang, H., Lu, W., & Shan, M. (2019) · Journal of Surgery · doi:10.11648/j.js.20190706.15
“However, some meta analysis showed that tight glycemic control may lead to no mortality benefit to all critically ill adults [11].”
BackgroundZhou, T. (2019) · UC Research Repository (University of Canterbury) · doi:10.26021/2871
Glucose-lowering medication selection in patients with diabetes and acute cerebrovascular accident
Занозина, О. В., Sorokina, Y. А., & Ловцова, Л. В. (2020) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2020-1-2378
Zinter, M. S., Wong, K. M. Y., Markovic, D., Pellegrini, M. A., Balliu, B., Gala, K. P., Asaro, L. A., Nadkarni, V., McQuillen, P. S., Vangala, S., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4054463
Lin, S., Ge, S., He, W., & Zeng, M. (2020) · Research Square · doi:10.21203/rs.3.rs-55105/v1
Glycemic Control and Stress Ulcer Prophylaxis
Gotur, D. B., & Zimmerman, J. L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88271-2.00033-x
Intestinal Failure in Critical Care
Itzhaki, M. H., & Singer, P. (2023) · Springer eBooks · doi:10.1007/978-3-031-22265-8_13
Cano, A. M. P., Barbosa, J., & Merchán-Chaverra, R. A. (2024) · Revista de Nutrición Clínica y Metabolismo · doi:10.35454/rncm.v7n1.592
Contemporary Approach to Trauma and Emergency Surgery
Karcioglu, O., & Akman, C. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1001692
Neurographien des Nervus facialis im Verlauf kritischer Krankheiten
Lochter, M. (2024) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10492
Tanaka, A., Yatabe, T., Suhara, T., & Egi, M. (2024) · Figshare · doi:10.6084/m9.figshare.26706294
Self-citationTanaka, A., Yatabe, T., Suhara, T., & Egi, M. (2024) · Figshare · doi:10.6084/m9.figshare.26706291
Self-citationDesgrouas, M., Demiselle, J., Stiel, L., Brunot, V., Marnai, R., Sarfati, S., Fiancette, M., Lambiotte, F., Thille, A. W., Leloup, M., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23537648
Tanaka, A., Yatabe, T., Suhara, T., & Egi, M. (2024) · Figshare · doi:10.6084/m9.figshare.26706288
Self-citationTanaka, A., Yatabe, T., Suhara, T., & Egi, M. (2024) · Figshare · doi:10.6084/m9.figshare.25602546
Self-citationTanaka, A., Yatabe, T., Suhara, T., & Egi, M. (2024) · Figshare · doi:10.6084/m9.figshare.26706285
Self-citationTanaka, A., Yatabe, T., Suhara, T., & Egi, M. (2024) · Figshare · doi:10.6084/m9.figshare.26706297
Self-citationTanaka, A., Yatabe, T., Suhara, T., & Egi, M. (2024) · Figshare · doi:10.6084/m9.figshare.25602601
Self-citationComisso, I., Fonda, F., Bressan, S., Vuerich, F., Maserin, M., Narduzzi, B., & Bove, T. (2026) · Dimensions of Critical Care Nursing · doi:10.1097/dcc.0000000000000769
Bludau, A., Naim, J., Marquet, M., Boenniger, M. M., Schiller, N. R., Misailovski, M., Geisler, R., Eckmanns, T., Marschollek, M., Pletz, M. W., et al. (2026) · Journal of Hospital Infection · doi:10.1016/j.jhin.2026.06.020
Liu, H., 张庆红, Du, M., Hao, J., 牛玉梅, You, H., Cao, D., Tang, R., 杨艳艳, Wei, X., et al. (2026) · Clinical Nutrition · doi:10.1016/j.clnu.2026.106740
Glucosa en las primeras 24horas de UCI y mortalidad a 90 días en pacientes con lesión renal aguda
Tirado, A. G. (2026) · Acta Colombiana de Cuidado Intensivo · doi:10.1016/j.acci.2026.100644
ความเกี่ยวข้องระหว่างโรคเบาหวานกับโรคหลอดเลือดสมอง: ทบทวนวรรณกรรมที่เกี่ยวข้อง
Burton, A. R., & Chumnanvej, S. (2023) · Journal of Thai Stroke Society
Metadata
- Authors
- Yatabe, T., Inoue, S., Sakaguchi, M., & Egi, M.
- Affiliations
- Kōchi University (JP)
- Tokai University Hachioji Hospital (JP)
- Kobe University Hospital (JP)
- Corresponding author
- Egi, Moritoki
- Venue
- Intensive Care Medicine
- Published
- 2016-09-29
- Volume
- 43
- Issue
- 1
- Pages
- 16-28
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W2525551153
- Semantic Scholar
- ea31613a90266d8f04dfe741f9bf9801f6bd49e4
- Cited by
- 95
- References
- 57
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 17 · 2023: 11 · 2022: 7 · 2021: 9 · 2020: 13 · 2019: 12 · 2018: 8 · 2017: 4 · 2016: 1
- FWCI
- 8.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Intensive Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (16K10936)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Keywords
- glycemic control, glycemic targets, critically ill patients, insulin therapy, hypoglycemia, in-hospital mortality, sepsis, bloodstream infection, intensive care
- MeSH terms
- Adult, Aged, Aged, 80 and over, Blood Glucose, Female, Humans, Hyperglycemia, Hypoglycemia, Hypoglycemic Agents, Male, Middle Aged, Critical Illness, Drug Dosage Calculations
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.